Prellis Biologics, Inc — Form D
Prellis Biologics, Inc of Hayward, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-06. The offering totals $35.0M, of which $17.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-07-06
- Form: D
- Accession: 0001711459-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $17.0M
- Remaining: $18.0M
- Investors: 19
- Date of first sale: 2022-06-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-451265
Issuer
- Name: Prellis Biologics, Inc
- CIK: 0001711459
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 3944 Trust Way, Hayward, CA, 94545
- Phone: (415) 742-1283
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Shaun Holt | Director | Hayward, CA |
| Michael Marks | Director | San Mateo, CA |
| Melanie Matheu | Director | Hayward, CA |
| Lei Meng | Director | Hayward, CA |
| Alex Morgan | Director | Austin, TX |
| SEAN O'SULLIVAN | Director | PRINCETON, NJ |
| Melanie Matheu | Executive Officer | Hayward, CA |
| ARVIND GUPTA | Director | SAN FRANCISCO, CA |
| Rohit Sharma | Director | Longmont, CO |
| Noelle Mullin | Director | San Francisco, CA |
| Noelle Mullin | Executive Officer | San Francisco, CA |
Other filings by this issuer (4)
More